Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Construction will begin this year with the new capacity anticipated by 2025
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions
The Awards recognizes standout digital health & medical technology products and companies
Pheezee is designed to assess musculoskeletal and neuromuscular health.
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Subscribe To Our Newsletter & Stay Updated
